U.S. flag

An official website of the United States government

GTR Home > Conditions/Phenotypes > 3-methylglutaconic aciduria type 5

3-methylglutaconic aciduria type 5

Synonyms
3 alpha methylglutaconic aciduria type V; 3-methylglutaconic aciduria type V; CARDIOMYOPATHY, DILATED, WITH ATAXIA; MGA 5; MGA, TYPE V
Modes of inheritance
Autosomal recessive inheritance (Orphanet)

Summary

3-Methylglutaconic aciduria type V is an autosomal recessive disorder characterized by the onset of dilated or noncompaction cardiomyopathy in infancy or early childhood. Many patients die of cardiac failure. Other features include microcytic anemia, growth retardation, mild ataxia, mild muscle weakness, genital anomalies in males, and increased urinary excretion of 3-methylglutaconic acid. Some patients may have optic atrophy or delayed psychomotor development (summary by Davey et al., 2006 and Ojala et al., 2012). For a discussion of genetic heterogeneity of 3-methylglutaconic aciduria, see MGCA type I (250950). [from OMIM]

Available tests

46 tests are in the database for this condition.

Check Related conditions for additional relevant tests.

Clinical tests (46 available)

Molecular Genetics Tests

Genes See tests for all associated and related genes

  • Also known as: PAM18, TIM14, TIMM14, DNAJC19
    Summary: DnaJ heat shock protein family (Hsp40) member C19

Clinical features

Help
Imported from Human Phenotype Ontology (HPO)

Show allHide all

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.